Cooper Companies | الأصول



Assets تغيير تاريخ
Abbott USD 84B 2.55B 2025-06
Align Technology USD 6.22B 116.27M 2025-06
AtriCure USD 608.85M 17.22M 2025-06
Avanos Medical USD 1.04B 68.8M 2025-06
Bausch Health Companies USD 27.27B 845M 2025-06
Baxter International USD 21.3B 4.48B 2025-03
Bayer EUR 105.24B 3.95B 2025-06
Becton, Dickinson and Co. USD 54.9B 435M 2025-06
Boston Scientific USD 40.14B 745M 2025-03
Cooper Companies USD 12.41B 191.4M 2025-04
Dentsply International USD 6.07B 19M 2025-06
Dexcom USD 7.33B 575.3M 2025-06
Edwards Lifesciences USD 13.02B 33M 2025-03
Globus Medical USD 4.96B 249.94M 2025-06
Haemonetics USD 2.46B 11.15M 2025-06
Hologic USD 8.81B 261M 2025-06
Insulet USD 3.47B 48.1M 2025-06
Integra LifeSciences USD 3.67B 384.85M 2025-06
Intuitive Surgical USD 20.16B 942.8M 2025-06
J&J USD 193.67B 13.57B 2025-03
Medtronic USD 91.68B 1.71B 2025-04
Merit Medical Systems USD 2.59B 118.07M 2025-06
Novartis USD 102.25B 1.28B 2024-12
ResMed USD 8.17B 607.57M 2025-06
STAAR Surgical USD 437.78M 19.58M 2025-06
Steris USD 10.4B 258.19M 2025-06
Stryker USD 46.33B 325M 2025-06
Tandem Diabetes Care USD 875.74M 46.41M 2025-06
Teleflex USD 7.38B 211.93M 2025-06
Zimmer Biomet Holdings USD 22.87B 681.2M 2025-06


Cooper Companies الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.